After the transaction, Myers Woodrow A Jr's stake was reported as 2,891 shares of Genomic Health Inc stock. In addition, Myers Woodrow A Jr performed several other transactions, including using transaction codes 'M' (exercise, usually of options).
As noted on February 15, 2013, Myers Woodrow A Jr's sale was done directly over 1 transaction on February 14, 2013. The share price for the transaction was $28.4 according to the regulatory filing detailing the trade.
If we look over the past 12 months, Myers Woodrow A Jr has sold a total of 41,250 shares of Genomic Health Inc, proceeds from the sale totaled $1,171,529. Over the same time period, Myers Woodrow A Jr has purchased no shares of Genomic Health Inc stock. Myers Woodrow A Jr has also performed other transactions including exercise of options .
Let's take a quick, high-level look at insider trading at Genomic Health Inc over the past 12 months. A total of 445,635 shares of Genomic Health Inc stock was sold by insiders, totaling $13,878,029. Over the same time 12 month time period, 3,150,683 shares of Genomic Health Inc, for a total value of $92,310,675 were purchased by company insiders.
To view the complete SEC Filing: Genomic Health Inc Form 4 (Insider Trading) SEC Filing
